Notice2022-28552

National Heart, Lung, and Blood Institute; Notice of Closed Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
January 4, 2023

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 2 (Wednesday, January 4, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 2 (Wednesday, January 4, 2023)]
[Notices]
[Page 363]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-28552]



[[Page 363]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and contract proposals and 
the discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications and 
contract proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; NHLBI Contract Review.
    Date: February 2, 2023.
    Time: 1:00 p.m. to 4:30 p.m.
    Agenda: To review and evaluate contract proposals
    Place: National Institutes of Health, Rockledge 1, 6705 
Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Kristen Page, MD, Scientific Review Officer, 
Office of Scientific Review/DERA, National Heart, Lung, and Blood 
Institute, 6705 Rockledge Drive, Room 209B, Bethesda, MD 20892, 301-
827-7953, <a href="/cdn-cgi/l/email-protection#dfb4adb6acabbab1f1afbeb8ba9fb1b6b7f1b8b0a9"><span class="__cf_email__" data-cfemail="f79c859e84839299d987969092b7999e9fd9909881">[email&#160;protected]</span></a>.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Early Phase Clinical Trials (R61/R33).
    Date: February 9, 2023.
    Time: 10:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge I, 6705 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Manoj K. Valiyaveettil, Ph.D., Scientific Review 
Officer, Blood & Vascular Branch, Office Scientific Review, Division 
of Extramural Research Activities (DERA), National Institute of 
Health, National Heart, Lung, and Blood Institute, Bethesda, MD 
20817, (301) 402-1616, <a href="/cdn-cgi/l/email-protection#8de0ece3e2e7a3fbece1e4f4ecfbe8e8f9f9e4e1cde3e4e5a3eae2fb"><span class="__cf_email__" data-cfemail="016c606f6e6b2f77606d6878607764647575686d416f68692f666e77">[email&#160;protected]</span></a>.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; New Epidemiological Cohort Study among Asian 
Americans, Native Hawaiians, and Pacific Islanders: Coordinating 
Center (U24).
    Date: February 14, 2023.
    Time: 9:00 a.m. to 11:30 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge I, 6705 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Fungai Chanetsa, Ph.D., MPH, Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6705 Rockledge 
Drive, Room 206-B, Bethesda, MD 20817, (301) 402-9394, 
<a href="/cdn-cgi/l/email-protection#5234273c35333b7c313a333c37262133123c3b3a7c353d24"><span class="__cf_email__" data-cfemail="deb8abb0b9bfb7f0bdb6bfb0bbaaadbf9eb0b7b6f0b9b1a8">[email&#160;protected]</span></a>.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; New Epidemiological Cohort Study among Asian 
Americans, Native Hawaiians, and Pacific Islanders: Clinical/
Community Field Centers (UG3-UH3).
    Date: February 14-15, 2023.
    Time: 11:30 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge I, 6705 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Fungai Chanetsa, Ph.D., MPH, Scientific Review 
Officer, Office of Scientific Review/DERA National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6705 Rockledge 
Drive, Room 206-B, Bethesda, MD 20817, (301) 402-9394, 
<a href="/cdn-cgi/l/email-protection#3355465d54525a1d505b525d56474052735d5a5b1d545c45"><span class="__cf_email__" data-cfemail="2741524940464e09444f46494253544667494e4f09404851">[email&#160;protected]</span></a>.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Phase II SBIR Topic 110 Proposals.
    Date: February 22, 2023.
    Time: 11:00 a.m. to 1:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Rockledge I, 6705 
Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Fungai Chanetsa, Ph.D., MPH, Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6705 Rockledge 
Drive, Room 206-B, Bethesda, MD 20817, (301) 402-9394, 
<a href="/cdn-cgi/l/email-protection#f492819a93959dda979c959a91808795b49a9d9cda939b82"><span class="__cf_email__" data-cfemail="0f697a61686e66216c676e616a7b7c6e4f61666721686079">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: December 28, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-28552 Filed 1-3-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on January 4, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.